PART Ⅰ Ethical Debates on Synthetic Biology
1 An Analysis of the “Playing God” Argument against Synthetic Biology
1.1 Introduction
1.2 The Origin of “Playing God” Argument
1.3 The Interpretation of the Expression of Playing God
1.4 The Debate on Whether Synthetic Biology “Plays God”
1.5 Deficiencies of “Playing God” as an Argument
1.6 References
2 Some Remarks on the Argument Appealing to Nature against Synthetic Biology
2.1 Introduction
2.2 The Argument Appealing to Nature against Synthetic Biology and an Analysis of Its Deficiencies
2.3 Ambiguity of the Concept Nature
2.4 Problems in the Morally Significant Line between the Natural and the Non/Unnatural
2.5 Allegations to Synthetic Biology Stemming from Argument Appealing to Nature
2.6 Conclusion
2.7 References
3 On the Biocentrist Argument against Synthetic Biology
3.1 Introduction
3.2 Biocentrism and Its Advocates: A Critique of Synthetic Biology
3.3 Argument Appealing to Natural Evolutionary History
3.4 Argument Appealing to Teleological Organization
3.5 Argument Appealing to the Good of Own or Interests
3.6 References
4 Research on Responsibility Ethics of DNA Synthesis Technology
4.1 Introduction
4.2 Ethics of Responsibility of Hans Jonas
4.3 The Necessity of Applying Ethics of Responsibility in DNA Synthesis Techniques
4.4 Application of Ethics of Responsibility in the Practice of DNA Synthesis Technology
4.5 Suggestions for Applying Ethics of Responsibility in the Practice of DNA Synthesis Technology
4.6 Conclusion
4.7 References
5 Analysis of Ethics Dumping and Proposed Solutions in the Field of Biomedical Research in China
5.1 Introduction
5.2 The Definition of Ethics Dumping
5.3 Typical Cases of Ethics Dumping in Biomedical Research in China
5.4 Analysis of the Causes of Ethics Dumping in Biomedical Research in China
5.5 Policy Recommendations
5.6 References
PART Ⅱ Risk Analysis in Synthetic Biology
6 Safety Risks and Ethical Governance of Biomedical Applications of Synthetic Biology
6.1 Introduction
6.2 The Biomedical Applications of Synthetic Biology
6.3 An Analysis of the Safety Risks of the Application of Synthetic Biology within Biomedicine
6.4 Ethical Considerations in the Application of Synthetic Biology within the Biomedical Field
6.5 Recommendations for Ethical Governance of Biomedical Applications of Synthetic Biology
6.6 Conclusion
6.7 References
7 Risks and Governance Recommendation for Synthetic Virus Technology from an Ethical Perspective
7.1 Introduction
7.2 Synthetic Virus Technology and Kinds of Risks
7.3 Challenges Faced by Existing Risk Governance Strategies
7.4 Governance Recommendations for Synthetic Virus Technology
7.5 Conclusion
7.6 References
8 Ethical Perspective on the Risk Assessment and Prospective Governance of Synthetic Biofuels
8.1 Introduction
8.2 Risk Assessment and Ethical Issues of Synthetic Biofuels
8.3 Prospective Governance of Synthetic Biofuels from an Ethical Perspective
8.4 Conclusion
8.5 References
9 Challenges and Principled Responses to Privacy Protection from Biometric Technology in China
9.1 Introduction
9.2 The Definition of Biometric Technology and Biometric Characteristics
9.3 The Challenges of Biometric Technology for Privacy Protection
9.4 Principled Responses to Privacy Protection from Biometric Technology
9.5 Conclusion
9.6 References
PART Ⅲ Governance Countermeasures in Synthetic Biology
10 Ethical Framework on Risk Governance of Synthetic Biology
10.1 Introduction
10.2 The Relationship between Environmental Risk and Synthetic Biology
10.3 Methods for Environmental Risk Assessment of Synthetic Biology
10.4 Ethical Principles in Environmental Risk Governance
10.5 Conclusion
10.6 References
11 Establishing a Management Framework for Biosafety Risk Assessments of Synthetic Biology
11.1 Introduction
11.2 Synthetic Biology Enabling Technology
11.3 Biosafety Risk Assessments of Synthetic Biology
11.4 Framework for Biosafety Risk Assessments
11.5 Discussion
11.6 Summary
11.7 References
12 Risks and Countermeasures of LaboratoryAcquired Infection Based on Pathogen Transmission Routes
12.1 Introduction
12.2 LAI Risk Analysis Based on Transmission Routes
12.3 Response to LAIs with Different Transmission Routes
12.4 Comprehensive Strategy
12.5 Conclusion
12.6 References
13 Regulation and Management of the Biosecurity for Synthetic Biology
13.1 Introduction
13.2 Biosecurity Risks of Synthetic Biology
13.3 Situation of the Regulation and Management of Biosecurity for Synthetic Biology in the International Community
13.4 Situation of the Regulation and Management of Biosecurity for Synthetic Biology in China
13.5 Suggestions on the Regulation and Management of Biosecurity for Synthetic Biology in China
13.6 Conclusion
13.7 References
14 Can Synthetic Biological Products Be Applied to the Cartagena Protocol on Biosafety?
14.1 Introduction
14.2 Progress in the Negotiation of Synthetic Biology under the Framework of the CBD
14.3 Application of Synthetic Biological Products under the Rules of the Biosafety Protocol
14.4 Conclusion
14.5 References
15 A Leap of Faith: Building the Trust in Human Biobanks
15.1 Introduction
15.2 Theoretical Foundations of Public Trust in HBs: A Leap of Faith
15.3 Is There a Universal Formula for the Construction of Public Trust in HBs?
15.4 Schemes for the Establishment and Reinforcement of Public Trust in HBs
15.5 Conclusion
15.6 References